Article Text

Download PDFPDF

What can we learn from top-cited articles in inflammatory bowel disease? A bibliometric analysis and assessment of the level of evidence
  1. Samy A Azer1,
  2. Sarah Azer2
  1. 1 College of Medicine, King Saud University, Riyadh, Saudi Arabia
  2. 2 St Vincent Hospital, University of Melbourne, Melbourne, Victoria, Australia
  1. Correspondence to Professor Samy A Azer; azer2000{at}optusnet.com.au

Abstract

Background and objectives Despite increasing number of publications in inflammatory bowel disease (IBD), no bibliometric analysis has been conducted to evaluate the significance of highly cited articles. Our objectives were to identify the top-cited articles in IBD, assessing their characteristics and determining the quality of evidence provided by these articles.

Design and outcome measures IBD and related terms were used in searching the Web of Science to identify English language articles. The 50 top-cited articles were analysed by year, journal impact factor (JIF), authorship, females in authorship, institute, country and grants received. The level of evidence was determined using the Oxford Centre for Evidence-Based Medicine guidelines.

Results The number of citations varied from 871 to 3555 with a total of 74 638, and a median 1339.50 (IQR=587). No correlations were found between the number of citations and number of years since publication (r=0.042, p=0.771), JIF (r=0.186, p=0.196), number of authors (r=0.061, p=0.674), females in authorship (r=0.064, p=0.661), number of institutes (r=0.076, p=0.602), number of countries (r=0.101, p=0.483) or number of grants (r=−0.015, p=0.915). The first authors were from the USA (n=24), the UK (n=6), Germany (n=5), France (n=5), Belgium (n=3) and Canada (n=3). The levels of evidence were 12 articles at level 1b, 9 articles at level 3a and 15 articles at level 3b and fewer were at other levels.

Conclusions Research papers represented 66% of articles. The majority of items have reasonably high levels of evidence, which may have contributed to the higher number of citations. The study also shows a gender gap in authorship in this area.

  • inflammatory bowel disease (ibd)
  • ulcerative colitis (uc)
  • crohn’s disease (cd)
  • bibliometric analysis
  • top-cited articles
  • quality of evidence

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SAA and SA shared equally the different roles and responsibilities to complete the submitted article including the research idea, the search of databases, the evaluation of data collected, the statistical analysis, the interpretation of findings, the creation of tables and figures, writing the manuscript and the approved the final version of the manuscript.

  • Funding This work was funded by the College of Medicine, Research Center Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No further data available to share.